This content is machine translated Multiple sclerosis Better long-term prognosis thanks to modern treatment options Over the past two decades, the arsenal of disease-modifying therapies for multiple sclerosis (MS) has expanded considerably. This applies in particular to the relapsing-remitting form (RRMS), but the treatment options...…
View Post 3 min This content is machine translated Multiple sclerosis Personalized medicine in the focus of treatment management Do we need more therapies? This question is being asked more and more frequently at congresses. The reason for this is the large number of new approvals in recent years.…
View Post 3 min This content is machine translated Alzheimer Early detection and perspectives in therapy management Even though the pathophysiology of Alzheimer’s has not yet been fully identified, it is known that the complex disease manifests itself around 20 years before the first symptoms appear. CSF-based…
View Post 4 min This content is machine translated Multiple sclerosis Taking a closer look at the challenges of MS research From scientific sessions to topical issues, ECTRIMS addressed the most important questions facing MS and neurological experts today. The program included inspiring keynote speeches from renowned international MS experts as…
View Post 4 min This content is machine translated Multiple sclerosis Predicting and reducing disease activity – what is the current status? Leading experts in the field of neurology met again this year at the world’s largest meeting for research into MS. The focus was on the clinical aspects of the disease,…
View Post 7 min This content is machine translated Multiple sclerosis Current treatment management of relapsing-remitting MS Various therapeutic strategies are available for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biologic agents. Although each of these therapies reduces relapse frequency and…
View Post 7 min This content is machine translated Parkinson's disease and movement disorders Digitalization on the rise for effective treatment strategies This year, the congress committee focused on “Technology-supported treatment strategies – current practice and future prospects”. In doing so, they paved the way for new ways of biomarker-based diagnosis of…
View Post 7 min This content is machine translated Multiple sclerosis Focus on genetic processes, early diagnostics and differential diagnoses Despite the difficult times that have existed in recent years, both the treatment and the journey of people living with and affected by MS have continued to evolve. New data…
View Post 2 min This content is machine translated Multiple sclerosis Glatiramer acetate now also approved for use in the breastfeeding period Glatiramer acetate 20 mg/ml and 40 mg/ml, indicated for the treatment of relapsing forms of multiple sclerosis (RMS) in Europe, has updated its SmPC. The product is now approved for…
View Post 3 min This content is machine translated Multiple sclerosis Improving quality of life as a goal of effective treatment Effective treatment of multiple sclerosis goes well beyond just MRI findings or blood work. Physical and mental well-being is at least as important for those affected. Therefore, more and more therapies…
View Post 3 min This content is machine translated Multiple sclerosis When movement is restricted: treatment options for spasticity Multiple sclerosis is the disease with a thousand faces. Not every patient is affected by every symptom. However, far too many sufferers often take the limitations for granted. For example,…
